Alkermes, Inc. Press Releaseshttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-news&nyo=0A Collection of Alkermes, Inc. Press Releasesen-usUncategorizedFri, 10 Sep 2010 06:45:53 GMTAlkermes Reports First Quarter Fiscal 2011 Financial Resultshttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1457242Uncategorized1457242_NEWSThu, 05 Aug 2010 20:02:00 GMTAlkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2011http://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1454002Uncategorized1454002_NEWSThu, 29 Jul 2010 20:00:46 GMTBYDUREON™ Safety and Tolerability Pooled Summary Data Presented at ADA 2010http://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1441833Uncategorized1441833_NEWSSat, 26 Jun 2010 17:31:00 GMTAlkermes Announces Notification of Tentative FDA Advisory Committee Meeting to Review VIVITROL® for Opioid Dependencehttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1439540Uncategorized1439540_NEWSThu, 17 Jun 2010 20:00:00 GMTDURATION-4 Study Results: BYDUREON™ Efficacy and Tolerability Profile Extended to Monotherapy Treatmenthttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1438160Uncategorized1438160_NEWSTue, 15 Jun 2010 12:16:00 GMTAlkermes' Corporate Presentation to be Webcast at Two Upcoming Conferenceshttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1433737Uncategorized1433737_NEWSWed, 02 Jun 2010 20:01:00 GMTAlkermes Announces Priority Review by FDA for VIVITROL® for Opioid Dependencehttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1430723Uncategorized1430723_NEWSTue, 25 May 2010 12:02:00 GMTData on VIVITROL® to be Presented at Upcoming American Psychiatric Association Annual Meetinghttp://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1428822Uncategorized1428822_NEWSWed, 19 May 2010 12:31:00 GMTAlkermes Reports Financial Results for Fiscal 2010 and Provides Financial Expectations for Fiscal 2011http://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1426642Uncategorized1426642_NEWSThu, 13 May 2010 20:03:00 GMTBYDUREON™ FDA Review Timeline Set with PDUFA Action Date of October 22, 2010http://investor.alkermes.com/phoenix.zhtml?c=92211&p=RssLanding&cat=news&id=1423433Uncategorized1423433_NEWSThu, 06 May 2010 12:30:00 GMT